Yatsen, a Chinese cosmetics company, rose as much as 70% on Thursday after raising $627M in its U.S. initial public offering. Meanwhile, NeoGames' stock rose as much as 35% on its first trading day after the company raised $81.7M in its IPO.

LATEST IPOS:

Maravai Lifesciences (MRVI) opened on November 20 at $31.95. The company had priced 60M shares at $27.00. The deal size was increased to 60M shares from 50M and priced at high end of $24.00-$27.00 range. Morgan Stanley, Jefferies and Goldman Sachs acted as joint book running managers for the offering. Maravai Lifesciences provides a range of nucleic acids and other products and services to biopharmaceutical research companies worldwide.

Sotera Health (SHC) opened on November 20 at $27. The company had priced 46.6M shares at $23.00. The deal priced at the high end of its $20.00-$23.00 range. JPMorgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citi and RBC Capital acted as joint book running managers for the offering. Sotera Health is a mission-critical sterilization, lab testing and advisory services provider.

Yatsen (YSG) opened on November 19 at $17.51. The company had priced 58.75M shares at $10.50, the high-end of the $8.50-$10.50 range. Goldman Sachs, Morgan Stanley and CICC acted as joint book running managers for the offering. Yatsen is a Chinese cosmetics company.

NeoGames (NGMS) opened on November 19 at $21.15. The company had priced 4.81M shares at $17.00. The deal size was increased from 4.18M shares and priced above the $14.00-$16.00 target range. Stifel acted as lead book running manager for the offering. NeoGames is a lottery solutions provider. The company currently supplies lotteries across Europe and North America with its B2B technology.

Telos (TLS) opened on November 19 at $21.90. The company had priced 14.969M shares at $17.00. The deal size was increased to 14.97M shares of common stock from 12.4M shares of common stock and the range was $16.00-$18.00. B. Riley Securities, BMO Capital and Needham acted as joint book running managers for the offering. Telos is a provider of cyber, cloud and enterprise security solutions.

Olema Pharmaceuticals (OLMA) opened on November 19 at $45. The company had priced 11M shares at $19.00. The deal size was increased to 11M shares from 10M and priced above the $16.00-$18.00 range. JPMorgan, Jefferies, Cowen and Canaccord acted as joint book running managers for the offering. Olema has recently entered into collaboration with Novartis (NVS) to evaluate the combination of its lead product candidate OP-1250 and Novartis’ Kisqali as well as Piqray.

SPAC IPOS:

Lifesci Acquisition II (LSAQ) opened on November 20 at $9.96 per share after its 7.5M share IPO priced at $10.00. The blank check company targeting the biopharma sector intends to pursue prospective targets that are focused on healthcare innovation in North America or Europe.

Consonance-HFW Acquistion (CHFW) opened on November 19 at $9.90. The blank check company had priced its initial public offering of 8M units at $10.00 per unit. Consonance-HFW expects that its focus will be on the healthcare industry, particularly the biotechnology sector, in developed countries including, but not limited to, the United States and countries in Europe.

Reinvent Technology Partners Z (RTPZ) opened on November 19 at $11.01. The blank check company had priced its initial public offering of 20M units at $10.00 per unit. Reinvent Technology Partners Z intends to focus its search for a target business operating in the technology sectors.

Jiya Acquisition (JYAC) opened on November 19 at $10. The blank check company had priced its initial public offering of 10M Class A shares at $10.00. Jiya Acquisition intends to focus its search for a target business operating in the biotechnology and pharmaceuticals sector.

OTR Acquisition (OTRA) opened on November 17 at $9.91. The blank check company had priced of its initial public offering of 10M units at $10.00 per unit. OTR intends to focus its search on target businesses with enterprise values of approximately $500M to $2.5B.

Zanite Acquisition (ZNTE) opened on November 17 at $10.04. The blank check company had priced its initial public offering of 20M units at $10.00 per unit. Zanite intends to focus on companies in the aviation, aerospace and defense, urban mobility and emerging technologies industries.

Pine Island Acquisition (PIPP) opened on November 17 at $9.90. The blank check company had priced its initial public offering of 20M units at a price of $10.00 per unit. Pine Island intends to focus on businesses in the defense, government service and aerospace industries.

PERFORMANCE:

• Sotera Health finished Friday at $25.10 after opening at $27.
• Maravai Lifesciences ended its first trading day at $29.85.
• Yatsen finished the week at $20.03.
• After opening at $21.15, NeoGames ended Friday at $20.75.
• Telos finished the week at $19.06.
• Olema Pharmaceuticals ended Friday at $48.90.

UPCOMING IPOS: Among the upcoming IPOs are Airbnb (AIRB), DoorDash (DASH), Affirm (AFRM), Roblox (RBLX), New Residential Investment (NRZ), Caliber Home Loans (HOMS), and Sigilon Therapeutics (SGTX).

On November 13, DoorDash filed its S-1 with the SEC for its initial public offering. The company plans to list on the NYSE under the ticker "DASH." The offering is being led by Goldman Sachs and JPMorgan. In 2019 and during the nine months ended September 30, 2020, the company generated revenue of $885M and $1.9B, respectively. In 2019 and during the nine months ended September 30, 2020, they had a net loss of $667M and $149M, respectively, and ($475M) and $95M, respectively, in Adjusted EBITDA, the filings with the SEC reveal.

Airbnb, the home rental company, has announced that it confidentially submitted a draft registration Statement on Form S-1 to the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.

On November 18, Affirm Holdings announced that it has filed a registration statement on Form S-1 with the U.S. SEC relating to a proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Affirm intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol "AFRM." Affirm, which was co-founded by Max Levchin, a co-founder of PayPal (PYPL), says it is "building the next generation platform for digital and mobile-first commerce, making it easier for consumers to spend responsibly and with confidence, easier for merchants to convert sales and grow, and easier for commerce to thrive." The payments startup lets consumers pay for goods in installments.

On November 20, gaming platform Roblox officially filed with the SEC for its IPO. The company, which has seen its child-friendly videogame platform's sales soar amid the pandemic, said in its filing that it averaged 31.1 million daily active users across 180 countries during the first nine months of the year. The company plans to list on the New York Stock Exchange under the ticker
"RBLX."

New Residential Investment jumped in Friday trading after the company announced that an affiliate of NewRez, a mortgage lending and servicing organization, has confidentially submitted a draft registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of NewRez's common stock. The number of shares of common stock to be sold and the price range for the proposed initial public offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process.

Caliber Home Loans is a financial services company and an approved Seller/Servicer for both Fannie Mae and Freddie Mac, an approved issuer for Ginnie Mae and is an approved servicer for FHA, VA and the USDA.

Sigilon Therapeutics is developing functional cures for chronic diseases through its Shielded Living Therapeutics platform. Sigilon was founded by Flagship Pioneering in conjunction with Daniel Anderson, Ph.D., and Robert Langer, Sc.D., of the Massachusetts Institute of Technology.

"Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, analyst commentary and upcoming IPOs.